Evidence map›Paper›PMID 31399344›Full record

ArticleMolecular cell2019

The Histone Deacetylase SIRT6 Restrains Transcription Elongation via Promoter-Proximal Pausing.

Jean-Pierre Etchegaray, Lei Zhong, Catherine Li, Telmo Henriques, Eileen Ablondi, Tomoyoshi Nakadai, Capucine Van Rechem, Christina Ferrer, Kenneth N Ross, Jee-Eun Choi and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 68 citations in OpenAlex.

  1. Research progress on lysine acetylation (Review).International journal of molecular medicine · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Insulation between adjacent TADs is controlled by the width of their boundaries through distinct mechanisms.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 1 country.

Jean-Pierre EtchegarayThe Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA. Electronic address: etchegje@newark.rutgers.edu.
Lei ZhongThe Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.
Catherine LiThe Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.
Telmo HenriquesDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Eileen AblondiDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Tomoyoshi NakadaiLaboratory of Biochemistry and Molecular Biology, The Rockefeller University, New York, NY 10065, USA.
Capucine Van RechemThe Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.
Christina FerrerThe Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.
Kenneth N RossThe Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.
Jee-Eun ChoiThe Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.
Ann SamarakkodyUniversity of North Dakota School of Medicine, Grand Forks, ND 58201, USA.
Fei JiDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Andrew ChangThe Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.
Ruslan I SadreyevDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Sridhar RamaswamyThe Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.
Sergei NechaevUniversity of North Dakota School of Medicine, Grand Forks, ND 58201, USA.
Johnathan R WhetstineThe Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.
Robert G RoederLaboratory of Biochemistry and Molecular Biology, The Rockefeller University, New York, NY 10065, USA.
Karen AdelmanDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Alon GorenDepartment of Medicine, University of California San Diego, La Jolla, CA 92093, USA. Electronic address: agoren@ucsd.edu.
Raul MostoslavskyThe Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA; The MGH Center for Regenerative Medicine, Harvard Medical School, Boston, MA 02114, USA; The Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA. Electronic address: rmostoslavsky@mgh.harvard.edu.
Harvard University · USMassachusetts General Hospital · USRockefeller University · USUniversity of North Dakota · USUniversity of California, San Diego · US

Funding

ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI CHRISTOPHER P DUGGAN · 1994 to 2026
$31.6M
Nuclear Receptor Coactivator Functions and MechanismsR01DK071900 · NIDDK · ROCKEFELLER UNIVERSITY · PI ROEDER, ROBERT G · 2005 to 2015
$5.9M
Mechanisms of p53 target gene activation in DNA damage responsesR01CA129325 · NCI · ROCKEFELLER UNIVERSITY · PI ROEDER, ROBERT G · 2007 to 2011
$4.0M
Understanding the Role of Histone Demethylases and Heterochromatin in Cell CycleR01GM097360 · NIGMS · RESEARCH INST OF FOX CHASE CAN CTR · PI WHETSTINE, JOHNATHAN R. · 2012 to 2020
$3.4M
The Role of SIRT6 and Metabolism in APC Mediated TumorigenesisR01CA175727 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI MOSTOSLAVSKY, GUSTAVO, MOSTOSLAVSKY, RAUL · 2014 to 2018
$2.6M
The histone deacetylase SIRT6 modulates Transcriptional pausingR01GM128448 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI MOSTOSLAVSKY, RAUL · 2019 to 2022
$1.6M
A high throughput assay to identify novel chromatin factors that regulate DNA repairR21ES027931 · NIEHS · MASSACHUSETTS GENERAL HOSPITAL · PI MOSTOSLAVSKY, RAUL · 2018 to 2019
$463k
NCI NIH HHS R01 CA129325NCI NIH HHS R01 CA175727NIDDK NIH HHS P30 DK040561NIDDK NIH HHS R01 DK071900NIEHS NIH HHS R21 ES027931NIGMS NIH HHS R01 GM097360NIGMS NIH HHS R01 GM128448
6 · The paper itself

Abstract

Transcriptional regulation in eukaryotes occurs at promoter-proximal regions wherein transcriptionally engaged RNA polymerase II (Pol II) pauses before proceeding toward productive elongation. The role of chromatin in pausing remains poorly understood. Here, we demonstrate that the histone deacetylase SIRT6 binds to Pol II and prevents the release of the negative elongation factor (NELF), thus stabilizing Pol II promoter-proximal pausing. Genetic depletion of SIRT6 or its chromatin deficiency upon glucose deprivation causes intragenic enrichment of acetylated histone H3 at lysines 9 (H3K9ac) and 56 (H3K56ac), activation of cyclin-dependent kinase 9 (CDK9)-that phosphorylates NELF and the carboxyl terminal domain of Pol II-and enrichment of the positive transcription elongation factors MYC, BRD4, PAF1, and the super elongation factors AFF4 and ELL2. These events lead to increased expression of genes involved in metabolism, protein synthesis, and embryonic development. Our results identified SIRT6 as a Pol II promoter-proximal pausing-dedicated histone deacetylase.

Indexed as

Promoter Regions, GeneticTranscription Elongation, GeneticAcetylationBromodomain Containing ProteinsCell Cycle ProteinsCell LineGene DeletionHistonesHumansProto-Oncogene Proteins c-mycRNA Polymerase IISirtuinsTranscriptional Elongation FactorsTranscription FactorsAFF4 protein, humanBRD4 protein, humanBromodomain Containing ProteinsCell Cycle ProteinsELL2 protein, humanHistonesMYC protein, humanNSMF protein, humanPAF1 protein, humanProto-Oncogene Proteins c-mycRNA Polymerase IISIRT6 protein, humanSirtuinsTranscriptional Elongation FactorsTranscription FactorsBRD4chromatinepigeneticshistone deacetylationNELFSIRT6transcriptional pausingtranscription elongation

Identifiers

PMID31399344
PMCPMC6907403
OpenAlexW2966060610

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.